An evaluation of methods for producing low-titer group O whole blood to support military trauma resuscitation

Journal of Trauma and Acute Care Surgery

Volumn 82, Issue 6, 2017, Pages S79-S86

  Belin, Tamara R ^a   Yazer, Mark H ^b   Meledeo, Michael A ^c   Fahie, Roland L ^a   Malloy, Wilbur W ^d   Stubbs, James R ^e   Cap, Andrew P ^c  

^a Armed Services Blood Program Office   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

^d U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP B ANTIGEN; FRESH FROZEN PLASMA; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; N ACETYLGALACTOSAMINE;

ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; BLOOD GROUP O; BLOOD STORAGE; BLOOD TRANSFUSION REACTION; CENTRIFUGATION; CRYOPRECIPITATE; DILUTION; ERYTHROCYTE TRANSFUSION; GLYCOSYLATION; HUMAN; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SEROLOGY; SUSPENSION; THROMBOCYTE TRANSFUSION; TITRIMETRY; BLOOD COMPONENT THERAPY; BLOOD GROUP ABO SYSTEM; BLOOD SAFETY; EVALUATION STUDY; HEMORRHAGIC SHOCK; INJURY; MILITARY MEDICINE; PREVENTIVE HEALTH SERVICE; PROCEDURES; PUBLIC HOSPITAL; SOLDIER; UNITED STATES;

ABO BLOOD-GROUP SYSTEM; BLOOD COMPONENT TRANSFUSION; BLOOD PRESERVATION; BLOOD SAFETY; HOSPITALS, MILITARY; HUMANS; MILITARY MEDICINE; MILITARY PERSONNEL; MOBILE HEALTH UNITS; RESUSCITATION; SHOCK, HEMORRHAGIC; UNITED STATES; WOUNDS AND INJURIES;

EID: 85015915255     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000001437     Document Type: Review

References (62)

1. Spinella PC, Dunne J, Beilman GJ, O'Connell RJ, Borgman MA, Cap AP, Rentas F. Constant challenges and evolution of US military transfusion medicine and blood operations in combat. Transfusion. 2012;52(5):1146-1153.
2. ZNessen SC, Eastridge BJ, Cronk D, Craig RM, Berseus O, Ellison R, Remick K, Seery J, Shah A, Spinella PC. Fresh whole blood use by forward surgical teams in Afghanistan is associated with improved survival compared to component therapy without platelets. Transfusion. 2013;53(Suppl 1): 107S-113S.
3. Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, del Junco DJ, Brasel KJ, Bulger EM, Callcut RA, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471-482.
4. Spinella PC, Perkins JG, Grathwohl KW, Beekley AC, Holcomb JB. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma. 2009;66(Suppl 4): S69-S76.
5. Manno CS, Hedberg KW, Kim HC, Bunin GR, Nicolson S, Jobes D, Schwartz E, Norwood WI. Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children. Blood. 1991;77(5):930-936.
6. Gerhardt RT, Strandenes G, Cap AP, Rentas FJ, Glassberg E, Mott J, Dubick MA, Spinella PC, Network T, Rem TSG. Remote damage control resuscitation and the Solstrand Conference: defining the need, the language, and a way forward. Transfusion. 2013;53(Suppl 1):9S-16S.
7. Cohen B, Matot I. Aged erythrocytes: a fine wine or sour grapes? Br J Anaesth. 2013;111(Suppl 1):i62-i70.
8. Lacroix J, Hebert PC, Fergusson DA, Tinmouth A, Cook DJ, Marshall JC, Clayton L, McIntyre L, Callum J, Turgeon AF, et al. Age of transfused blood in critically ill adults. N Engl J Med. 2015;372(15):1410-1418.
9. Spinella PC, Acker J. Storage duration and other measures of quality of red blood cells for transfusion. JAMA. 2015;314(23):2509-2510.
10. Steiner ME, Ness PM, Assmann SF, Triulzi DJ, Sloan SR, Delaney M, Granger S, Bennett-Guerrero E, Blajchman MA, Scavo V, et al. Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med. 2015;372(15):1419-1429.
11. Heddle NM, Cook RJ, Arnold DM, Liu Y, Barty R, Crowther MA, Devereaux PJ, Hirsh J, Warkentin TE, Webert KE, et al. Effect of short-term vs. long-term blood storage on mortality after transfusion. N Engl J Med. 2016;375(20):1937-1945.
12. Perkins JG, Cap AP, Spinella PC, Shorr AF, Beekley AC, Grathwohl KW, Rentas FJ, Wade CE, Holcomb JB. Comparison of platelet transfusion as fresh whole blood versus apheresis platelets for massively transfused combat trauma patients (CME). Transfusion. 2011;51(2):242-252.
13. Strandenes G, Berseus O, Cap AP, Hervig T, Reade M, Prat N, Sailliol A, Gonzales R, Simon CD, Ness P, et al. Low titer group O whole blood in emergency situations. Shock. 2014;41(Suppl 1):70-75.
14. Technical Manual. 18th ed. Bethesda, MD: AABB; 2014.
15. Yazer MH, Jackson B, Sperry JL, Alarcon L, Triulzi DJ, Murdock AD. Initial safety and feasibility of cold-stored uncrossmatched whole blood transfusion in civilian trauma patients. J Trauma Acute Care Surg. 2016;81(1):21-26.
16. + whole blood in civilian trauma patients: initial experience at a Level 1 trauma centre. Transfus Med. 2016;27(1):30-35.
17. Neel S. Vietnam Studies: Medical Support of the US Army in Vietnam 1965-1970. Washington DC: Department of the Army; 1991 [cited October 1, 2013]. Available at: http://history.amedd.army.mil/booksdocs/vietnam/medicalsupport/defaulthtml. Accessed April 12, 2017.
18. Kendrick DB. ChapterXX: TheBlood, Plasma, and Related Programs in the Korean War. Washington, DC: Office of the Surgeon General; 1964 [cited October 1, 2013]. Available at: http://history.amedd.army.mil/booksdocs/wwii/blood/chapter20.htm. Accessed April 12, 2017.
19. Aubert EF, Dodd BE, Boorman KE, Loutit JF. The universal donor with high titre iso-agglutinins. Br Med J. 1942;1(4247):659-664.
20. Fung MK, Downes KA, Shulman IA. Transfusion of platelets containing ABO-incompatible plasma: a survey of 3156 North American laboratories. Arch Pathol Lab Med. 2007;131(6):909-916.
21. Clinical Practice Guidelines: Joint Trauma System; 2014 [cited November 20, 2014]. Available at: http://www.usaisr.amedd.army.mil/cpgs.html. Accessed April 12, 2017.
22. Daniels G, Bromilow I. Essential Guide to Blood Groups. 3rd ed. Malden, MA: Blackwell Publishing; 2013.
23. Cohen M, Hurtado-Ziola N, Varki A. ABO blood group glycans modulate sialic acid recognition on erythrocytes. Blood. 2009;114(17): 3668-3676.
24. Grove-Rasmussen M. Transfusion reactions. Bull Soc Int Chir. 1956;15(4): 334-344.
25. Cid J, Harm SK, Yazer MH. Platelet transfusion-the art and science of compromise. Transfus Med Hemother. 2013;40(3): 160-171.
26. AuBuchon JP, de Wildt-Eggen J, Dumont LJ, Biomedical Excellence for Safer Transfusion Collaborative; Transfusion Medicine Resource Committee of the College of American Pathologists. Reducing the variation in performance of antibody titrations. Vox Sang. 2008;95(1):57-65.
27. Josephson CD, Castillejo MI, Grima K, Hillyer CD. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies. Transfus Apher Sci. 2010;42(1):83-88.
28. Cooling LL, Downs TA, Butch SH, Davenport RD Anti-A and anti-B titers in pooled group O platelets are comparable to apheresis platelets. Transfusion. 2008;48(10):2106-2113.
29. Duez A, Flourie F, Garraud O. Antibodies titration for immunized pregnant women: conventional tube test or gel microcolumn assay. Transfusion. 2014;54(4):1200.
30. Quillen K, Sheldon SL, Daniel-Johnson JA, Lee-Stroka AH, Flegel WA. A practical strategy to reduce the risk of passive hemolysis by screening platelet pheresis donors for high-titer ABO antibodies. Transfusion. 2011;51(1): 92-96.
31. Novaretti MC, Jens E, Pagliarini T, Bonifacio SL, Dorlhiac-Llacer PE, Chamone DA. Comparison of conventional tube test with DiaMed gel microcolumn assay for anti-D titration. Clin Lab Haematol. 2003;25(5): 311-315.
32. Finck R, Lui-Deguzman C, Teng SM, Davis R, Yuan S. Comparison of a gel microcolumn assay with the conventional tube test for red blood cell alloan-tibody titration. Transfusion. 2013;53(4):811-815.
33. Josephson CD, Mullis NC, van Demark C, Hillyer CD. Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A, B: implications for Transfusion policy. Transfusion. 2004;44(6):805-808.
34. Berseus O, Boman K, Nessen SC, Westerberg LA. Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma. Transfusion. 2013;53(Suppl 1): 114S-123S.
35. Murphy MF, Hook S, Waters AH, Sterlini J, Whelan J, Davis C, Lister TA. Acute haemolysis after ABO-incompatible platelet transfusions. Lancet. 1990;335(8695):974-975.
36. Mair B, Benson K. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets. Transfusion. 1998; 38(1):51-55.
37. Fontaine MJ, Mills AM, Weiss S, Hong WJ, Viele M, Goodnough LT. How we treat: risk mitigation for ABO-incompatible plasma in platelet pheresis products. Transfusion. 2012;52(10):2081-2085.
38. Sadani DT, Urbaniak SJ, Bruce M, Tighe JE. Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction. Transfus Med. 2006;16(5):375-379.
39. Sapatnekar S, Sharma G, Downes KA, Wiersma S, McGrath C, Yomtovian R. Acute hemolytic transfusion reaction in a pediatric patient following trans-fusion of apheresis platelets. J Clin Apher. 2005;20(4):225-229.
40. Angiolillo A, Luban NL. Hemolysis following an out-of-group platelet transfusion in an 8-month-old with Langerhans cell histiocytosis. J Pediatr Hematol Oncol. 2004;26(4):267-269.
41. Barjas-Castro ML, Locatelli MF, Carvalho MA, Gilli SO, Castro V Severe immune haemolysis in a group A recipient of a group O red blood cell unit. Transfus Med. 2003;13(4):239-241.
42. Serious Hazards of Transfusion (SHOT) Annual Report 2003. Manchester, UK: SHOT Office; 2004.
43. Larsson LG, Welsh VJ, Ladd DJ. Acute intravascular hemolysis secondary to out-of-group platelet transfusion. Transfusion. 2000;40(8):902-906.
44. Valbonesi M, De Luigi MC, Lercari G, Florio G, Bruni R, van Lint MT, Occhini D. Acute intravascular hemolysis in two patients transfused with dry-platelet units obtained from the same ABO incompatible donor. Int J Artif Organs. 2000;23(9):642-646.
45. McManigal S, Sims KL. Intravascular hemolysis secondary to ABO incom-patible platelet products. An underrecognized transfusion reaction. Am J Clin Pathol. 1999;111(2):202-206.
46. Boothe G, Brecher ME, Root M, Robinson J, Haley R. Acute hemolysis due to passively transfused high-titer anti-B causing spontaneous in vitro agglutination. Immunohematology. 1995;11(2):43-45.
47. Chow MP, Yung CH, Hu HY, Tzeng CH. Hemolysis after ABO-incompatible platelet transfusions. Zhonghua Yi Xue Za Zhi (Taipei). 1991; 48(2): 131-134.
48. Reis MD, Coovadia AS. Transfusion of ABO-incompatible platelets causing severe haemolytic reaction. Clin Lab Haematol. 1989;11(3):237-240.
49. Ferguson DJ. Acute intravascular hemolysis after a platelet transfusion. CMAJ. 1988;138(6):523-524.
50. Pierce RN, Reich LM, Mayer K. Hemolysis following platelet transfusions from ABO-incompatible donors. Transfusion. 1985;25(1):60-62.
51. Conway LT, Scott EP Acute hemolytic transfusion reaction due to ABO incompatible plasma in a platelet apheresis concentrate. Transfusion. 1984;24(5): 413-414.
52. Inwood MJ, Zuliani B. Anti-A hemolytic transfusion with packed O cells. Ann Intern Med. 1978;89(4):515-516.
53. Lundberg WB, McGinniss MH. Hemolytic transfusion reaction due to anti-A. Transfusion. 1975;15(1):1-9.
54. Keidan SE, Lohoar E, Mainwaring D. Acute anuria in a haemophiliac; due to transfusion of incompatible plasma. Lancet. 1966;1(7430):179-182.
55. McLeod BC, Sassetti RJ, Weens JH, Vaithianathan T. Haemolytic transfu-sion reaction due to ABO incompatible plasma in a platelet concentrate. Scand J Haematol. 1982;28(3): 193-196.
56. Zoes C, Dube VE, Miller HJ, Vye MV Anti-A1 in the plasma of platelet con-centrates causing a hemolytic reaction. Transfusion. 1977;17(1):29-32.
57. Transfusion of apheresis platelets and ABO groups. Vox Sang. 2005;88(3): 207-221.
58. Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, Sebesta J, Jenkins D, Azarow K, Holcomb JB. Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital. Crit Care Med. 2007;35(11):2576-2581.
59. Gilstad C, Roschewski M, Wells J, Delmas A, Lackey J, Uribe P, Popa C, Jardeleza T, Roop S. Fatal transfusion-associated graft-versus-host disease with concomitant immune hemolysis in a group A combat trauma patient resuscitated with group O fresh whole blood. Transfusion. 2012;52(5): 930-935.
60. Reddy HL, Doane SK, Keil SD, Marschner S, Goodrich RP Development of a riboflavin and ultraviolet light-based device to treat whole blood. Transfusion. 2013;53(Suppl 1):131S-136S.
61. Sprogoe U, Rasmussen MH, Yazer M, Assing K. Variation in anti-A/-B titers over time-an observational study in healthy volunteers and in patients with end stage renal disease. Transfusion. 2016;56(Suppl S4):136A-137A.
62. Garratty G. Problems associated with passively transfused blood group alloantibodies. Am J Clin Pathol. 1998;109(6):769-777.